Skip to content
Screener

Passage Bio, Inc. PASG Q4 2025 Annual earnings

Reported March 3, 2026 · Before market open

EPS-$4.08Miss by $1.89
EPS estimate-$2.19

Next report

Nov 9, 2026 (in 2 months)
EPS estimate-$2.44

FAQ

When did Passage Bio, Inc. report Q4 2025 earnings?
Passage Bio, Inc. (PASG) reported Q4 2025 earnings on March 3, 2026 before market open.
What were Passage Bio, Inc.'s Q4 2025 revenue and EPS?
Passage Bio, Inc. reported eps of $-4.08 for Q4 2025.
Did Passage Bio, Inc. beat estimates in Q4 2025?
EPS missed the consensus estimate of $-2.19 by $1.89.
How did Passage Bio, Inc.'s Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps declined 1940.0% from $-0.20.
Where can I find Passage Bio, Inc.'s Q4 2025 SEC filings?
You can read the 8-K earnings release (0001104659-26-022539) and the 10-K periodic report (0001104659-26-022549) directly on SEC EDGAR. The filing index links above go to sec.gov.